Revio Therapeutics Llp - Company Profile

It is a infrastructure and utilities limited liability partnership based in Hyderabad, Telangana, India, established in 2020.
2020 Hyderabad, Telangana, India Active
Last Updated:
Access Report
About Revio Therapeutics Llp

Revio Therapeutics Llp, a active limited liability partnership, was established on 14 October 2020 in Hyderabad, Telangana, India. Engaging in general infrastructure services within the infrastructure and utilities sector, it holds LLPIN: AAU-2475. Registered under ROC Roc Hyderabad. It has total obligation of contribution of ₹1.01 Cr.

Its leadership includes Jyothi Raju Chintalapati (Designated Partner), Akila Chandrashekar Raju (Designated Partner), Duddukuri Venkata Dhanumjaya Rao (Designated Partner). Its latest date of accounts and solvency statement 31 March 2025. It is based at Ilabs Centre, Building No. Iii, No. 18, Software Units Layout, Madhapur, Hyderabad, Telangana, 500081.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    AAU-2475

  • Incorporation Date

    14 October 2020

  • Total Obligation of Contribution

    ₹1.01 Cr

  • ROC Code

    Roc Hyderabad

  • Company Status

    Active

Key Metrics
  • Obligation of Contribution ₹ 1.01 Cr
  • Company Age 5 Year, 4 Months
  • Last Filing with ROC 31 Mar 2025
Company report

Revio Therapeutics Llp

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Revio Therapeutics Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Revio Therapeutics Llp?
Current Designated Partners
Name Designation Appointment Date Status
Jyothi Raju Chintalapati Designated Partner 14 Oct 2020 Current
Akila Chandrashekar Raju Designated Partner 14 Oct 2020 Current
Duddukuri Venkata Dhanumjaya Rao Designated Partner 01 May 2025 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Revio Therapeutics Llp.

Enhance accessibility to Revio Therapeutics Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Revio Therapeutics Llp revenue growth over time
Revio Therapeutics Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Revio Therapeutics Llp?

Unlock access to Revio Therapeutics Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Revio Therapeutics Llp?

Unlock and access historical data on people associated with Revio Therapeutics Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Revio Therapeutics Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Revio Therapeutics Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Revio Therapeutics Llp
Recent Activity within the Organization
  • Director Appointment

    Progress on Duddukuri Venkata Dhanumjaya Rao was appointed as a Designated Partner was appointed as a Designated Partner on 01 May 2025 & has been associated with this company since 9 months 14 days . was documented.

  • Annual General Meeting

    The activity Revio Therapeutics Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records. was completed.

  • Statement of Assets & Liabilities

    Progress on Revio Therapeutics Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was documented.

  • Director Appointment

    Jyothi Raju Chintalapati was appointed as a Designated Partner was appointed as a Designated Partner on 14 Oct 2020 & has been associated with this company since 5 years 4 months . was recorded as a recent event.

  • Director Appointment

    The activity Akila Chandrashekar Raju was appointed as a Designated Partner was appointed as a Designated Partner on 14 Oct 2020 & has been associated with this company since 5 years 4 months . was completed.

  • LLP Incorporation

    Progress on Revio Therapeutics Llp was registered on 14 Oct 2020 with Roc Hyderabad & aged 5 years 4 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Revio Therapeutics Llp?

The LLPIN of Revio Therapeutics Llp is AAU-2475.

Where is Revio Therapeutics Llp headquartered?

Revio Therapeutics Llp is headquartered at Ilabs Centre, Building No. Iii, No. 18, Software Units Layout, Madhapur, Hyderabad, Telangana, 500081.

When was Revio Therapeutics Llp incorporated?

Revio Therapeutics Llp was incorporated on 14 October 2020.

Who are the current directors of Revio Therapeutics Llp?

The current directors of Revio Therapeutics Llp are

What is the primary industry of Revio Therapeutics Llp?

The primary industry of Revio Therapeutics Llp is Infrastructure And Utilities.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available